Amendment and Mail Process Complete

SYMERSE

Eli Lilly and Company

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 87853773 FILING DATE 03/28/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY JOHNSON, DANYTHE ELIZA
L.O. ASSIGNED N20-NOT FOUND

PUB INFORMATION

RUN DATE 01/17/2019
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 01/16/2019
LITERAL MARK ELEMENT SYMERSE

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT SYMERSE
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Eli Lilly and Company
ADDRESS Lilly Corporate Center
Indianapolis, IN 46285
ENTITY 03-CORPORATION
CITIZENSHIP Indiana

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Insulin delivery system, namely, disposable delivery system utilizing wireless technology, sold filled with insulin
INTERNATIONAL CLASS 009
          DESCRIPTION TEXT Computer software application for management of diabetes-related data; downloadable cloud computing software for use in managing diabetes by managing diabetes-related data, tracking insulin and glucose levels, and sending data to users
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Insulin pen module utilizing wireless technology, namely, dose detection and data transmission apparatus utilizing wireless technology adapted for insulin injection pens, sold empty
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Medical information services in the field of diabetes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 009 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/16/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 011
01/16/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 010
01/14/2019 ALIE A ASSIGNED TO LIE 009
01/09/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
07/19/2018 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED 007
07/19/2018 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED 006
07/19/2018 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY 005
07/19/2018 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED 004
07/12/2018 DOCK D ASSIGNED TO EXAMINER 003
04/05/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/31/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Bruce W. Longbottom
CORRESPONDENCE ADDRESS BRUCE W. LONGBOTTOM
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed